Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Alikhani

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Drug Delivery Science and Technology|May 1, 2023
Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: A double-blind clinical trial studyHamid Reza Samaee, Gohar Eslami, Golnar Rahimzadeh, et al.
The Journal of Antimicrobial Chemotherapy|August 20, 2020
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trialHamideh Abbaspour Kasgari, Siavash Moradi, Amir Mohammad Shabani, et al.
Scientific Reports|October 29, 2025
Sex-based differences in mortality among a large cohort of hospitalized patients with RT-PCR-confirmed SARS-CoV-2 infection at five different pandemic waves in Northern IranMahmood Moosazadeh, Erfan Ghadirzadeh, Majid Saeedi, et al.
Frontiers in Medicine|July 5, 2022
Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical TrialsMohammad Sadegh Rezai, Fatemeh Ahangarkani, Andrew Hill, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Drug Delivery Science and Technology|May 1, 2023
Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: A double-blind clinical trial studyHamid Reza Samaee, Gohar Eslami, Golnar Rahimzadeh, et al.
The Journal of Antimicrobial Chemotherapy|August 20, 2020
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trialHamideh Abbaspour Kasgari, Siavash Moradi, Amir Mohammad Shabani, et al.
Scientific Reports|October 29, 2025
Sex-based differences in mortality among a large cohort of hospitalized patients with RT-PCR-confirmed SARS-CoV-2 infection at five different pandemic waves in Northern IranMahmood Moosazadeh, Erfan Ghadirzadeh, Majid Saeedi, et al.
Frontiers in Medicine|July 5, 2022
Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical TrialsMohammad Sadegh Rezai, Fatemeh Ahangarkani, Andrew Hill, et al.
Pageof 3